Epidyolex 100 mg/ml oral solution
GWEP17005
Phase 3 small_molecule active
Quick answer
Epidyolex 100 mg/ml oral solution for Dravet Syndrome, Tuberous sclerosis complex, Lennox-Gastaut Syndrome is a Phase 3 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pharma Mar S.A.
- Indication
- Dravet Syndrome, Tuberous sclerosis complex, Lennox-Gastaut Syndrome
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active